Skip to main content
Signal8
Pisano Wayne profile photo

Wayne Pisano

CIK: 0001743611

Transaction Breakdown

Open Market Buys (P)2 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ONCOLYTICS BIOTECH INC logo
ONCY

ONCOLYTICS BIOTECH INC

Director
Altimmune, Inc. logo
ALT

Altimmune, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Jun 1, 2026
    Award(A)

    Stock Option

    Direct
    30K shares-
  • Altimmune, Inc. logo
    ALT

    Altimmune, Inc.

    May 1, 2026
    Award(A)

    Stock Options (option to buy)

    Direct
    48.8K shares-
  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Feb 12, 2026
    Purchase(P)
    Direct
    30K shares at avg. $0.84$25K
  • Altimmune, Inc. logo
    ALT

    Altimmune, Inc.

    Jan 8, 2026
    Purchase(P)
    Direct
    5K shares at avg. $4.08$20K
  • Altimmune, Inc. logo
    ALT

    Altimmune, Inc.

    Sep 25, 2025
    Award(A)

    Stock Options (option to buy)

    Direct
    48.8K shares-
  • Altimmune, Inc. logo
    ALT

    Altimmune, Inc.

    Sep 26, 2024
    Award(A)

    Stock Options (option to buy)

    Direct
    34.9K shares-

1-6 of 6

About Pisano Wayne

Pisano Wayne (SEC CIK 0001743611) files insider reports with the SEC as Director of ONCOLYTICS BIOTECH INC (ONCY) and Director of Altimmune, Inc. (ALT).

Signal8 holds 7 ownership filings by Pisano Wayne (1 Form 3, 6 Form 4), filed between Sep 30, 2024 and Jun 3, 2026. Those filings report 6 transactions, from Sep 26, 2024 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Pisano Wayne's filings is in SAN DIEGO, CA.

Recent filings by Pisano Wayne

  • Jun 1, 2026: Grant or award of ONCY derivative securities (Form 4, code A).
  • May 1, 2026: Grant or award of ALT derivative securities (Form 4, code A).
  • Feb 12, 2026: Open-market purchase of ONCY shares (Form 4, code P).
  • Jan 8, 2026: Open-market purchase of ALT shares (Form 4, code P).
  • Sep 25, 2025: Grant or award of ALT derivative securities (Form 4, code A).

Other insiders filing for ONCOLYTICS BIOTECH INC (ONCY)

How to read Form 4 transaction codes